Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5712)
All Articles published online
|
Publishing Process of This Article
|
May 16, 2022 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Najeeb H, Yasmin F, Surani S. Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients. World J Clin Cases 2022; 10(14): 4327-4333 [PMID: 35663066 DOI: 10.12998/wjcc.v10.i14.4327] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i14/4327.htm |
| Number | Citing Articles |
| 1 |
Tomas Gabriel Bas, Vannessa Duarte. Biosimilars in the Era of Artificial Intelligence—International Regulations and the Use in Oncological Treatments. Pharmaceuticals 2024; 17(7): 925 doi: 10.3390/ph17070925
|
| 2 |
Nicola Humphry. The Rise of Anti-TNF Biosimilars: Guidelines, Real-World Evidence, and Challenges to Acceptance. EMJ Gastroenterology 2022; : 2 doi: 10.33590/emjgastroenterol/10106137
|
| 3 |
Ariel A Jordan, Shubha Bhat, Tauseef Ali, Sarah R Brunskill, Nancy A Clusen, Ross M Maltz, Ced Moise, Xiaofan Sun, Harry J Thomas, Cassie Ray, Mary Harkins-Schwarz, Orna G Ehrlich. Healthcare Access for Patients With Inflammatory Bowel Disease in the United States: A Survey by the Crohn’s & Colitis Foundation. Inflammatory Bowel Diseases 2024; doi: 10.1093/ibd/izae237
|
| 4 |
Celia Gómez-Labrador, Elena Ricart, Marisa Iborra, Eva Iglesias, María Dolores Martín-Arranz, Luisa de Castro, Ruth De Francisco, Francisco Javier García-Alonso, Ana Sanahuja, Carla J. Gargallo-Puyuelo, Francisco Mesonero, María José Casanova, Míriam Mañosa, Montserrat Rivero, Marta Calvo, Mónica Sierra-Ausin, Carlos González-Muñoza, Xavier Calvet, Santiago García-López, Jordi Guardiola, Lara Arias García, Lucía Márquez-Mosquera, Ana Gutiérrez, Yamile Zabana, Mercè Navarro-Llavat, Rufo Lorente Poyatos, Marta Piqueras, Leyanira Torrealba, Fernando Bermejo, Ángel Ponferrada-Díaz, José L. Pérez-Calle, Manuel Barreiro-de Acosta, Coral Tejido, José Luis Cabriada, Ignacio Marín-Jiménez, Óscar Roncero, Yolanda Ber, Luis Fernández-Salazar, Blau Camps Aler, Alfredo J. Lucendo, Jordina Llaó, Luis Bujanda, Carmen Muñoz Villafranca, Eugeni Domènech, María Chaparro, Javier P. Gisbert. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA. Pharmaceutics 2024; 16(5): 629 doi: 10.3390/pharmaceutics16050629
|
| 5 |
Shannon White, Ryan Morrow, Ingrid Pan, Edwin F. de Zoeten. Riding the Wave of Adalimumab Biosimilars: Considerations for Pediatric Gastroenterologists. Journal of Pediatric Gastroenterology & Nutrition 2023; 76(6): 701 doi: 10.1097/MPG.0000000000003757
|